2 June 2010 - Lab21 has achieved its first product registration in China with a TPHA assay used in syphilis screening.
18 December 2009 - Lab21 has acquired Selah Technologies, a South Carolina-based company with proprietary nanotechnologies for use in in-vitro and in-vivo diagnostic products.
27 November 2009 - Lab21 has acquired from administrator BDO the business and assets of Delphic Diagnostics, a laboratory services company focused on personalised medicine and companion diagnostics.
17 September 2009 - Lab21, a healthcare diagnostics company, has signed an agreement with Astrazeneca under which it will provide a genetic testing service for oncologists in lung cancer.
22 July 2009 - Lab21 has announced the publication of its international patent application covering the use of syphilis antigens in immunodiagnostic applications.
